Screener
Nurix Therapeutics, Inc. NRIX Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Nurix Therapeutics, Inc.’s 10-Q, filed July 9, 2026.
- Filed
- Jul 9, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001549595-26-000040
| Line item | Three Months Ended May 31, 2026 | Three Months Ended May 31, 2025 | Six Months Ended May 31, 2026 | Six Months Ended May 31, 2025 |
|---|---|---|---|---|
| Total operating expenses | 103,247 | 92,378 | 201,994 | 173,695 |
| Loss from operations | (94,204) | (48,322) | (186,699) | (111,186) |
| Interest and other income, net | 4,398 | 5,618 | 9,719 | 12,131 |
| Loss before income taxes | (89,806) | (42,704) | (176,980) | (99,055) |
| Provision for (benefit from) income taxes | (271) | 760 | (271) | 760 |
| Net loss | $(89,535) | $(43,464) | $(176,709) | $(99,815) |
| Net loss per share, basic and diluted | $(0.81) | $(0.52) | $(1.60) | $(1.19) |
| Weighted-average number of shares outstanding, basic and diluted | 111,084,423 | 83,882,477 | 110,583,610 | 83,723,403 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Nurix Therapeutics, Inc.'s net income?
- Nurix Therapeutics, Inc. (NRIX) reported net income of -$89.54M in Q1 2026.
- How has Nurix Therapeutics, Inc.'s net income changed year-over-year?
- Nurix Therapeutics, Inc.'s net income decreased by 106.0% year-over-year, from -$43.46M to -$89.54M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s net income?
- Over 4 years (2021 to 2025), Nurix Therapeutics, Inc.'s net income has grown at a 22.6% compound annual growth rate (CAGR), from -$117.19M to -$264.46M.
- What does net income mean?
- Net income as the starting point for the indirect method operating cash flow reconciliation.
Ask your AI about Nurix Therapeutics, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude